QP 05 - Predicting Outcomes in Breast Cancer: From Multi-Omics to AI-Driven Models

Presentations

• 08:00am - 08:05am ET

  Introductions

  Speaker: Mona Arbab, MD, M.Ed - UT Southwestern Medical Center, Dallas
• 08:05am - 08:10am ET

  TP53 Mutations in Primary Breast Tumors Predict Brain Metastases: Insights from the MSK CHORD Cohort

  Speaker: Victor Lee, MD, BS - Yale New Haven Hospital, Middletown
• 08:10am - 08:15am ET

  Association of the Radiosensitivity Index with Overall Survival In Radiotherapy-Treated HER2+ and Triple-Negative Breast

  Speaker: Shivani Nellore, - Cleveland Clinic, Cleveland
• 08:15am - 08:20am ET

  Intratumoral Immune Remodeling and Tumor Regression following Preoperative Radiation in Estrogen Receptor Positive Breast Cancer: Results from a Prospective Clinical Trial

  Speaker: Gopika SenthilKumar, BS - University of Wisconsin, Madison
• 08:20am - 08:25am ET

  Association of Blood Count-Derived Inflammatory Indices with Capsular Contracture After Post-Mastectomy Radiotherapy in Breast Cancer Patients Undergoing Direct-to-Implant Reconstruction

  Speaker: Jae Young Lee, MD - Yonsei Cancer Center, Yonsei University College of Medicine, Seoul
• 08:25am - 08:30am ET

  Comparable Cosmetic Outcomes Across Racial and Age Groups After Dose-Escalated Five-Fraction Stereotactic Partial Breast Irradiation (S-PBI) on a Phase II Multicenter Trial

  Speaker: Chelsea Bolton, - University of Texas Southwestern Medical Center at Dallas, Dallas
• 08:30am - 08:35am ET

  SMART: A Multi-Center Clinical Practice Driven by an AI-Enhanced Human-in-the-Loop Workflow in Breast Cancer

  Speaker: Wei-Hong Zheng, - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 08:35am - 08:55am ET

  Questions & Answers

  Speaker: Elizabeth Nichols, MD, Professor - University of Maryland Radiation Oncology, Baltimore
• 08:55am - 09:00am ET

  Closing

  Speaker: Mona Arbab, MD, M.Ed - UT Southwestern Medical Center, Dallas